4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001193125-26-174417
Options or other derivatives
- Chief Executive Officer acquired 24,081 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
TABUTEAU HERRIOT · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-04-21 | Grant or award : show line 1 in the form Performance Stock Units | +24,081 | 24,081 | D |
Loading xslF345X06/ownership.xml…